HOME Top Market Reports European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

By: marketsandmarkets.com
Publishing Date: October 2015
Report Code: BT 3781

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.

On the basis of technology, the European NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor, sequencing by ligation (SBL), pyro-sequencing, and SMRT. SBS is currently the largest market and is also expected to be the fastest-growing technology segments. This can be attributed to the fact that SBS provides the highest reads per run and also offers high sequencing yields as compared to other technology segments in this market.

The U.K. is expected to dominate the European NGS services market in 2015 and is also expected to grow at the highest CAGR. The U.K.’s prominence in this market can be attributed to two major factors—presence of numerous small and medium-sized service providers and government support in the form of funding.

Prominent players in the European NGS services market include Beijing Genomics Institute (BGI) (China), Macrogen (South Korea), Eurofins Genomics (Germany), Illumina (U.S.), DNA Vision (Belgium), CeGaT GmbH (Germany), Febit (U.S.), Genomnia (Italy), Microsynth (Switzerland), and Source Bioscience (U.K.).

Scope of the Report

This report categorizes the European NGS services market into the following segments and subsegments:

European NGS Services Market, by Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor
  • Sequencing by Ligation (SBL)
  • Pyro-sequencing
  • SMRT

European NGS Services Market, by Application (I)

  • Whole-genome Sequencing
  • Exome Sequencing
  • Targeted Sequencing/Gene Panels
  • De Novo Sequencing
  • RNA-seq
  • ChiP-seq
  • Methyl-seq

European NGS Services Market, by Application (II)

  • Research Applications
  • Clinical Applications

European NGS Services Market, by Disease Type

  • Oncology
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
  • Inherited Rare Diseases
  • Prenatal/Neonatal Disorder
  • Other Diseases

European NGS Services Market, by End User

  • Research Centers and Academic & Government Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

European NGS Services Market, by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe (RoE)

Market Stakeholders:

  • NGS Equipment Manufacturers, Vendors, and Distributors
  • NGS Sequencing Services Companies
  • NGS Bioinformatics/Data Analysis Companies
  • Research Institutes and Government Organizations
  • Venture Capitalists and Other Government Funding Organizations
  • Research and Consulting Firms
  • Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics)
  • Pharmaceutical and Biotechnology Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Research Organizations (CROs)

Table of Contents

1 Introduction
    1.1 Objectives
    1.2 Market Definitions
    1.3 Market Scope

2 Research Methodology

3 Executive Summary

4 Market Overview
    4.1 Introduction
    4.2 Evolution
    4.3 Market Segmentation
    4.4 Market Dynamics
           4.4.1 Drivers
           4.4.2 Restraints
           4.4.3 Opportunities
           4.4.4 Challenges

5 Industry Insights
    5.1 Pricing Analysis
    5.2 Investor Analysis
    5.3 Pestel Analysis

6 Regulation and Certification Landscape

7 Customer Perception Analysis

8 Benchmark Parameters and Futuristic Trends

9 European NGS Services Market, By Technology
    9.1 SBS 
    9.2 ION Semiconductor
    9.3 SBL
    9.4 Pyro-Sequencing
    9.5 Smrt

10 European NGS Services Market, By Application
     10.1 Application (I)
             10.1.1 Research Applications
             10.1.2 Clinical Applications
     10.2 Application (II)
             10.2.1 Rna-Sequencing
             10.2.2 Targeted Sequencing
             10.2.3 Exome Sequencing
             10.2.4 Whole Genome Sequencing
             10.2.5 Chip-Sequencing
             10.2.6 Methyl-Sequencing
             10.2.7 De Novo Sequencing
             10.2.8 Others

11 European NGS Services Market, By Disease Type
     11.1 Overview
     11.2 Oncology
             11.2.1 Lung Cancer
             11.2.2 Breast Cancer
             11.2.3 Prostate Cancer
             11.2.4 Colorectal Cancer
             11.2.5 Others
     11.3 Rare Diseases
     11.4 Prenatal/Neonatal Disorders
     11.5 Others

12 European NGS Services Market, By End User
     12.1 Research Centers, Academic & Government Institutes
     12.2 Hospitals & Clinics
     12.3 Pharmaceutical & Biotechnology Companies
     12.4 Others

13 European NGS Services Market, By Geography
     13.1 Introduction
     13.2 U.K.
     13.3 Germany
     13.4 France
     13.5 Italy
     13.6 Spain
     13.7 Netherlands
     13.8 Rest of the Europe (RoE)

14 Competitive Landscape
     14.1 New Product Launches
     14.2 Government Funding
     14.3 Market Share Analysis

15 Company Profiles
     15.1 Beijing Genomics Institute (BGI)
     15.2 Cegat (Centre for Genomics and Transcriptomics)  GmbH
     15.3 DNA Vision SA
     15.4 Eurofins Genomics Inc.
     15.5 Febit / Comprehensive Biomarker Center GmbH (CBC)
     15.6 Genomnia Srl
     15.7 Illumina Inc. 
     15.8 Macrogen Inc. 
     15.9 Microsynth AG
     15.10 Seqomics 
     15.11 Source Bio Science

16 Appendix
     16.1 Certified NGS Service Providers in Europe
     16.2 Major End Users of NGS Services
     16.3 Related Reports


List of Tables (67 Tables)

Table 1 European NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 2 SBS Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 3 ION Semiconductor Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 4 SBL Technology-Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 5 Pyrosequencing Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 6 Smart Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 7 European NGS Services Market Size, By Application (I), 2013-2020 (USD Million)
Table 8 NGS Services Market Size for Research Applications, By Country, 2013-2020 (USD Million)
Table 9 NGS Services Market Size for Clinical Applications, By Country, 2013-2020 (USD Million)
Table 10 European NGS Services Market Size, By Application (II), 2013-2020 (USD Million)
Table 11 RNA-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 12 Targeted Sequencing/Gene Panels Services Market Size, By Country, 2013-2020 (USD Million)
Table 13 Exome Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 14 Whole Genome Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 15 Chip-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 16 Methyl-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 17 De Novo Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 18 Other Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 19 NGS Services Market Size, By Disease Type, 2013–2020 (USD Million)
Table 20 European NGS Oncology Services Market, By Cancer Type, 2013-2020 (USD Million)
Table 21 NGS Services Market Size for Lung Cancer, By Country, 2013-2020 (USD Million)
Table 22 NGS Services Market Size for Breast Cancer, By Country, 2013-2020 (USD Million)
Table 23 NGS Services Market Size for Prostate Cancer, By Country, 2013-2020 (USD Million)
Table 24 NGS Services Market Size for Colorectal Cancer, By Country, 2013-2020 (USD Million)
Table 25 NGS Services Market Size for Other Oncology Diseases, By Country, 2013-2020 (USD Million)
Table 26 European NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 27 NGS Services Market Size for Research Centers, Academic & Government Institutes, By Country, 2013-2020 (USD Million)
Table 28 NGS Services Market Size for Hospitals & Clinics, By Country, 2013-2020 (USD Million)
Table 29 NGS Services Market Size for Pharmaceutical & Biotechnology Companies, By Country, 2013-2020 (USD Million)
Table 30 NGS Services Market Size for Other End Users, By Country, 2013-2020 (USD Million)
Table 31 European NGS Services Market Size, By Country, 2013-2020 (USD Million)
Table 32 European Oncology NGS Services Market Size, By Country, 2013-2020 (USD Million)
Table 33 U.K.: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 34 U.K.: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 35 U.K.: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 36 U.K.: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 37 U.K.: NGS Oncology Services Market Size, By Type, 2013-2020 (USD Million)
Table 38 Germany: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 39 Germany: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 40 Germany: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 41 Germany: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 42 Germany: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 43 France: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 44 France: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 45 France: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 46 France: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 47 France: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 48 Italy: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 49 Italy: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 50 Italy: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 51 Italy: NGS Services Market Size, By Applications, (II) 2013-2020 (USD Million)
Table 52 Italy: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 53 Spain: NGS Services Market, By Technology Size, 2013-2020 (USD Million)
Table 54 Spain: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 55 Spain: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 56 Spain: NGS Services Market Size, By Applications (II) 2013-2020 (USD Million)
Table 57 Spain: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 58 Netherlands: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 59 Netherlands: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 60 Netherlands: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 61 Netherlands: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 62 Netherlands: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 63 RoE: NGS Services Market, By Technology Size, 2013-2020 (USD Million)
Table 64 RoE: NGS Services Market Size, By Applications(I), 2013-2020 (USD Million)
Table 65 RoE: NGS Services Market Size, By End-User , 2013-2020 (USD Million)
Table 66 RoE: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 67 RoE: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)


List of Figures (12 Figures)

Figure 1 Market Size, 2015-2020 (USD Million)
Figure 2 Customer Segmentation, 2015
Figure 3 Country-Wise Market Share, 2015
Figure 4 Market Size, 2014–2020 (USD Million)
Figure 5 Pricing Analysis
Figure 6 European NGS Services Market Size, By Technology, 2015 & 2020 (USD Million)
Figure 7 Market Size, By Technology, 2011–2020 (USD Million)
Figure 8 Market Size, By Applications (I), 2015 & 2020 (USD Million)
Figure 9 Market Size, By Application (II), 2015 & 2020 (USD Million)
Figure 10 Market Size, By Disease Type, 2015 & 2020 (USD Million)
Figure 11 Market Size, By End User, 2011–2020 (USD Million)
Figure 12 Market Share (2014)

The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference of NGS over other platforms; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities. On the other hand, factors such as lack of analytics, high dependence on grants for R&D, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.

The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country.

On the basis of technology, the European NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor, sequencing by ligation (SBL), pyro-sequencing, and SMRT. On the basis of application (I), the market is segmented into whole-genome sequencing, exome sequencing, targeted sequencing/gene panels, de novo sequencing, RNA-seq, ChiP-seq, and methyl-seq. On the basis of application (II), the market is segmented into research and clinical applications. On the basis of disease type, the market is segmented into oncology, inherited rare diseases, prenatal/neonatal disorder, and other diseases. The NGS oncology services market is further subsegmented into lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. On the basis of end users, the market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users.

European NGS Services Market

Regionally, the European NGS services market is segmented into the U.K., Germany, France, Italy, Spain, Netherlands, and Rest of Europe (RoE). Increasing healthcare expenditure and growth in NGS technologies are the major growth drivers in most of the regional segments.

The prominent players in the European NGS services market include Beijing Genomics Institute (BGI) (China), Macrogen (South Korea), Eurofins Genomics (Germany), Illumina (U.S.), DNA Vision (Belgium), CeGaT GmbH (Germany), Febit (U.S.), Genomnia (Italy), Microsynth (Switzerland), and Source Bioscience (U.K.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports